Kasumi
Kasumi Nakajima, Chigasaki-Shi JP
Patent application number | Description | Published |
---|---|---|
20130024466 | SYSTEM EVENT LOGGING SYSTEM - Provided is a system event logging system for recoding a log of system events which relate to a process being monitored, the logging system having the aim of selectively recording system events that are necessary for purposes such as the reproduction of operations and excluding system events that are outside the intended purpose. Flag conditions and flag operation instructions are provided for each of the filters in a filter list, and the system event logging system uses the flag conditions as the conditions for applying the filters. When applying the filters, the logging system operates the flags according to the flag operation instructions. Thus, interrelated operation between the filters can be achieved by means of the flags, and also, interrelated operation can be achieved by means of the flags even between the processes performed for the system events. | 01-24-2013 |
Kasumi Takeuchi, Ichihara-Shi JP
Patent application number | Description | Published |
---|---|---|
20150252221 | Curable Silicone Composition, Cured Product Thereof, And Optical Semiconductor - The present invention relates to a curable silicone composition comprising: (A) an organopolysiloxane having at least two alkenyl groups in a molecule and represented by the average unit formula; (B) a straight chain organopolysiloxane having at least two alkenyl groups in a molecule and having no silicon-bonded hydrogen atoms; (C) an organosiloxane i) represented by the general formula, an organopolysiloxane (C | 09-10-2015 |
20150329681 | Organopolysiloxane, Curable Silicone Composition, Cured Product Thereof, And Optical Semiconductor - The present invention relates to a curable silicone composition comprising: (A) an organopolysiloxane represented by a specific average unit formula, (B) an optional straight-chain organopolysiloxane having at least two alkenyl groups and not having any silicon-bonded hydrogen atoms in a molecule, (C) an organopolysiloxane having at least two silicon-bonded hydrogen atoms in a molecule, and (D) a hydrosilylation reaction catalyst. The curable silicone composition has high reactivity and forms a cured product with low gas permeability. | 11-19-2015 |
20150344692 | Curable Silicone Composition, Cured Product Thereof, And Optical Semiconductor Device - The present invention relates to a curable silicone composition comprising: (A) an organopolysiloxane resin having at least two alkenyl groups in a molecule; (B) an organopolysiloxane represented by a general formula; (C) an organosiloxane (C | 12-03-2015 |
Kasumi Takeuchi, Ichihra-Shi JP
Patent application number | Description | Published |
---|---|---|
20160027974 | Aryl Group-Containing Siloxane Compositions Including Alkaline Earth Metal - An aryl group-containing siloxane composition is formed by introducing an alkaline earth-metal as a part of the reaction product of an organopolysiloxane having at least two alkenyl groups per molecule and an organopolysiloxane having at least two silicon-bonded hydrogen atoms per molecule in the presence of a hydrosilylation catalyst, wherein at least one of the organopolysiloxanes includes an aryl group. The alkaline earth metal may be introduced via a heat stability composition or may alternatively be pre-reacted with the organopolysiloxane having at least two alkenyl groups per molecule. The aryl group-containing siloxane compositions may be utilized as an encapsulating layer for a light emitting device. | 01-28-2016 |
Kasumi Yagi, Ina-Shi JP
Patent application number | Description | Published |
---|---|---|
20140363832 | MOLECULAR MARKER FOR THE EARLY DETECTION OF MALIGNANT PLEURAL MESOTHELIOMA AND THE METHODS OF ITS EXPRESSION ANALYSIS USING BLOOD AND PLEURAL EFFUSION SAMPLES - The present invention provides a method for testing mesothelioma comprising a step of determining a concentration of a human periostin protein in at least one type of sample of blood or pleural fluid of a subject. In the step of determining the concentration of human periostin protein, an antibody directed against human periostin protein may be used. The present invention further provides a kit for diagnosing mesothelioma, said kit comprising an antibody directed against human periostin protein. In the kit for diagnosing mesothelioma, the antibody directed against a human periostin protein may be an antibody that binds to a polypeptide consisting of an amino acid sequence set out in SE ID NO: 2. | 12-11-2014 |
Kasumi Yagi, Itabashi-Ku, Tokyo JP
Patent application number | Description | Published |
---|---|---|
20160046706 | ANTIBODY AGAINST HUMAN NRG1 PROTEIN - An object is to provide an antibody capable of specifically recognizing a human NRG1 protein isoform, and suppressing signal transduction in which the isoform is involved. An antibody capable of binding to a region at positions 221 to 234 of a human NRG1-α protein or an antibody capable of binding to a region at positions 213 to 239 of a human NRG1-β1 protein was successfully obtained. Further, it was also found that these antibodies had an activity of suppressing cleavage of the NRG1 protein, an activity of suppressing phosphorylation of an ErbB3 protein in a cancer cell, and an activity of suppressing in vivo tumor proliferation. | 02-18-2016 |